FDA Weighing Off-Label Concerns Posed By Internet Bibliographies
This article was originally published in The Gray Sheet
Executive Summary
FDA is currently debating the extent to which off-label journal articles may be cited in bibliographies on device company websites.
You may also be interested in...
Product Data On the Web Linked To Advertising, Needs FTC Oversight - WLF
Internet product data is unnecessary for the proper use of medical devices and other FDA-regulated products, and should therefore be classified as advertising, the Washington Legal Foundation maintains in a citizen petition submitted to FDA April 13.
Arthrocare Removes Spine Claims Cited By FDA From Marketing Materials
Arthrocare has removed certain promotional materials and claims on its web site regarding the company's Orthopedic Electrosurgery System following a Feb. 26 warning letter from FDA.
EU Regulatory Assessors Get AI Boost In Reaching Scientific Decisions
The European Medicines Agency is training scientific staff working for the European medicines regulatory network in how to use a new AI-powered search engine that allows them to easily retrieve information on regulatory precedents.